Development

INSIGHTS ON DRUG DEVELOPMENT

Accelerating Clinical Development: Modern Tools In Process Chemistry
Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.
Improve Bioanalysis Workflows With Integrated Technologies
Improve bioanalysis workflows with integrated technologies designed for sensitive biomolecules. Explore how biocompatible systems can support sample integrity, reliable performance, and evolving needs.
Building A Science- And Risk-Based Bio-Decontamination Strategy
Annex 1 has made bio-decontamination central to sterility assurance, with isolator and barrier cycles now expected to be designed, justified, and reviewed across their lifecycle.
Advancing Next Gen Antibodies: From AI Driven CLD To Manufacturing
See how growing ADC complexity is driving the adoption of AI-enabled, data-driven CMC strategies that accelerate development, improve product insight, and strengthen manufacturing readiness.

A Comparison To Traditional Clone Screening Platforms
8/6/2026

See how 46 CHO clones performed across automated, deep-well, and microbioreactor fed-batch cultures, using cell density, viability, and IgG concentration to evaluate clone performance.
Ask Us Anything: Daniele Vigo On Cost-Effective Process Development
7/23/2026

Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.
Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development
1/15/2026

Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.
Biocatalysis 101: Faster, Greener API Manufacturing
4/20/2026

View how enzyme-driven reactions accelerate pharmaceutical ingredient manufacturing, improve selectivity, reduce waste, lower costs, and support scalable, sustainable processes under mild conditions.
Building A Human-Centric Future For Biologics Development
6/25/2026

Biologics are advancing rapidly, but complexity challenges traditional models. Gain insight into how human-relevant approaches like NAMs and microphysiological systems are gaining traction.

Controlled Substances

Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing, and importation of Schedule I to IV controlled substances.
Process Liquid Preparation Services

We simplify pre-production workflows—for both upstream and downstream—by delivering fit-for-purpose process liquid and buffer preparation solutions that enable you to produce life-changing therapeutics and vaccines, faster.
Accelerate Molecules Through Development With Translational Pharmaceutics®

By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.
Pharmaceutical Tablet Presses

Natoli’s line of affordable tablet presses is designed, engineered, and manufactured in the U.S.A. and built on our decades of experience in the tableting industry. We know our customers want presses that efficiently meet their R&D and/or production needs.

With Natoli you have a choice in your tablet press: R&D or production, single-station or rotary, fully automated or manual. Whatever your need, Natoli’s best-in-class tablet presses can help you optimize tablet quality while saving time and reducing costs.
Automated Cell Imaging System

Integrate an automated cell imaging system with high-resolution imaging and robust analytics into your processes to streamline workflows for fluorescence and brightfield assays.